Gilead trades that made millions on COVID-19 drug news raise eyebrows
NEW YORK/WASHINGTON (Reuters) - Well-timed trades in Gilead Sciences Inc’s (GILD.O) options ahead of good news on the biopharmaceutical company’s COVID-19 drug treatment may draw…